The doorway is narrow. The threshold is high. Through it, I can see a wooden bed, pushed against the wall, barely wide enough for an adult body. The room beyond is small, dim, and preserved exactly as it was when patients lived and died here.

St. Jorgens Hospital in Bergen wasn't just a hospital. It was one of the last leper colonies in Europe. People entered and, for most of history, they didn't leave. Their disease marked them. Their bodies betrayed them. Their condition was understood not as biology, but as divine punishment.

Then, in 1873, a physician named Armauer Hansen bent over a microscope in this very building and changed everything.

Before Hansen, leprosy was a curse. Sometimes hereditary, sometimes divine, always a mark of something wrong with the person who had it. Societies built leper colonies not primarily to prevent transmission, but to separate the afflicted from the normal. Out of sight. Out of community. Out of the moral fabric of regular life.

Hansen discovered Mycobacterium leprae. He identified the bacterium under his microscope, right here in Bergen, and proved that leprosy was an infection. A biological process. A pathogen that could be studied, tracked, and eventually treated.

The moral weight didn't vanish overnight. Stigma never moves that fast. But the trajectory changed. Once you name a pathogen, you've moved the condition from the realm of character to the realm of medicine. The patient is no longer being punished. The patient is being infected.

This is the same pathway diabetes followed.

Before 1922, Type 1 diabetes was also a death sentence. The symptoms were observable: excessive thirst, frequent urination, wasting of the body despite eating. Ancient physicians noticed that the urine of diabetics tasted sweet. They called it "mellitus," honey.

But like leprosy, the condition was often moralized. Something was wrong with the patient. Something in their constitution, their habits, their character. The inability to control the body was read as the inability to control the self.

Then Banting, Best, Macleod, and Collip isolated insulin in Toronto. Within months, people who would have died were living. The condition didn't stop existing. But it stopped being a death sentence. And more importantly, it stopped being understood primarily as a failure of the person.

Hansen's microscope and Banting's insulin syringe accomplished the same thing: they shifted chronic illness from moral category to biological category. The moment you can point at a pathogen, or a missing hormone, or a measurable deficiency, you've changed the social contract.

The patient is no longer morally suspect. The patient is medically understood.

Walking through the preserved wards of St. Jorgens, I keep thinking about the bodies that lay in these beds. People whose symptoms made them outcasts. People who were physically separated from family, community, work. Not because isolation would cure them, but because their presence was considered contaminating in ways that went beyond infection.

The beds are cramped. The rooms are dark. The threshold I stepped over, carefully, with a healing Achilles, was designed to mark a boundary between the healthy world and the quarantine.

Modern diabetes doesn't involve physical quarantine. We live among everyone else. But the psychological isolation can be just as real. The sense that your body is different. That its failures are somehow your failures. That the exhaustion of management is a personal weakness rather than the inevitable cost of living with a chronic condition.

Standing in the leprosy wards, I felt the weight of that history. The line from these beds to my glucose monitor is not metaphorical. It's the actual progression of how medicine has learned to see chronic disease.

Hansen's microscope is still here. Not a replica. The actual instrument. I stood in front of it for a long time.

We live now in an era of continuous data. My CGM streams glucose readings to my phone every five minutes. The granularity of the information is extraordinary. I know things about my body that no one in history could have known about theirs.

But Hansen only needed one moment of seeing. One glimpse of the bacillus under magnification. One instant where the invisible became visible. That was enough to change everything.

The microscope is small. The monitor on my arm is small. Both devices do the same thing: they make the invisible interior of the body available to the clinical gaze. They turn the mysterious into the measurable. They move disease from the realm of fate into the realm of science.

There's a larger story here about how we name illness, how that naming changes how we treat people, and how technology mediates that shift. It's a story I'm increasingly interested in telling. Not just the practical "here's how to travel with diabetes" content, but the deeper question of what it means to live with a body that requires monitoring, measurement, and intervention just to stay alive.

That's a story for another format, another time. For now, I'm leaving the museum with two images: the narrow beds, and the microscope. The container and the instrument. The isolation and the insight that eventually ended it.

Know someone navigating recovery with diabetes? Forward this to them. The best way you can help me is to help somebody else.